双相情感障碍全基因组关联研究:发现两个新易感位点及跨人群多基因性
与PGC-BD荟萃分析后鉴定NFIX为新基因(Pbest=5.8×10-10),并支持MAD1L1、TRANK1、ODZ4三个既往位点。风险谱评分分析显示日本人群内及跨欧洲-日本人群均存在多基因性,遗传相关估计约0.7。
要点
- 日本人群GWAS发现11q12.2(rs28456)与双相障碍显著关联(P=6.4×10-9)。
- 与PGC-BD荟萃分析鉴定NFIX为新易感基因(Pbest=5.8×10-10)。
- 风险谱评分支持日本与欧洲人群间双相障碍风险效应共享。
核心结论
- 两个新位点(11q12.2和NFIX)及三个既往位点(MAD1L1、TRANK1、ODZ4)与双相障碍显著关联。
- 双相障碍风险效应在日本与欧洲人群间共享,支持跨人群多基因性。
研究设计与样本
- 后续对Phase I/II与PGC-BD进行荟萃分析,并用风险谱评分评估多基因性。
主要发现
- 新易感位点11q12.2(rs28456,P=6.4×10-9),该区域含FADS1/2/3调控基因。
- 荟萃分析鉴定NFIX(Pbest=5.8×10-10),并支持MAD1L1(Pbest=1.9×10-9)、TRANK1(Pbest=2.1×10-9)、ODZ4(Pbest=3.3×10-9)。
- 日本人群内风险谱评分比较:Pbest~10-29,R2~2%。
- 跨欧洲-日本人群风险谱评分比较:Pbest~10-13,R2~0.27%。
- 基于各人群效应量估计的遗传相关(liability estimates)~0.7。
关键数值与推荐
- 日本人群GWAS显著位点:11q12.2 rs28456,P=6.4×10-9。
- 荟萃分析显著基因:NFIX Pbest=5.8×10-10;MAD1L1 Pbest=1.9×10-9;TRANK1 Pbest=2.1×10-9;ODZ4 Pbest=3.3×10-9。
- 风险谱评分:日本人群内Pbest~10-29、R2~2%;跨欧洲-日本Pbest~10-13、R2~0.27%。
- 遗传相关liability estimates~0.7。
临床怎么用
- 提示双相障碍遗传风险跨人群共享,支持跨人群遗传研究策略。
- 发现的新位点可为双相障碍生物学机制研究提供候选区域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome-wide association studies (GWASs) have identified several susceptibility loci for bipolar disorder (BD) and shown that the genetic architecture of BD can be explained by polygenicity, with numerous variants contributing to BD. In the present GWAS (Phase I/II), which included 2964 BD and 61 887 control subjects from the Japanese population, we detected a novel susceptibility locus at 11q12.2 (rs28456, P=6.4 × 10-9), a region known to contain regulatory genes for plasma lipid levels (FADS1/2/3). A subsequent meta-analysis of Phase I/II and the Psychiatric GWAS Consortium for BD (PGC-BD) identified another novel BD gene, NFIX (Pbest=5.8 × 10-10), and supported three regions previously implicated in BD susceptibility: MAD1L1 (Pbest=1.9 × 10-9), TRANK1 (Pbest=2.1 × 10-9) and ODZ4 (Pbest=3.3 × 10-9). Polygenicity of BD within Japanese and trans-European-Japanese populations was assessed with risk profile score analysis. We detected higher scores in BD cases both within (Phase I/II) and across populations (Phase I/II and PGC-BD). These were defined by (1) Phase II as discovery and Phase I as target, or vice versa (for 'within Japanese comparisons', Pbest~10-29, R2~2%), and (2) European PGC-BD as discovery and Japanese BD (Phase I/II) as target (for 'trans-European-Japanese comparison,' Pbest~10-13, R2~0.27%). This 'trans population' effect was supported by estimation of the genetic correlation using the effect size based on each population (liability estimates~0.7). These results indicate that (1) two novel and three previously implicated loci are significantly associated with BD and that (2) BD 'risk' effect are shared between Japanese and European populations.
引用
- Ikeda M, Takahashi A, Kamatani Y, et al. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry. 2017. PMID: 28115744. doi:10.1038/mp.2016.259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。